Yimitasvir

Identification

Generic Name
Yimitasvir
DrugBank Accession Number
DB18768
Background

Not Available

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 855.053
Monoisotopic: 854.44793162
Chemical Formula
C49H58N8O6
Synonyms
Not Available
External IDs
  • DAG 181
  • DAG-181
  • DAG181

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Yimitasvir phosphate7HJK69JC341959593-63-5KRUXCUGAHYWSKK-UHFFFAOYSA-N

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
K465JAH79P
CAS number
1959593-23-7
InChI Key
CMLNPOWEANUBIB-XIGHHNHFSA-N
InChI
InChI=1S/C49H58N8O6/c1-26(2)42(54-48(60)62-5)46(58)56-21-7-9-38(56)44-50-25-37(53-44)29-13-11-28(12-14-29)33-18-19-34(41-32-16-15-31(23-32)40(33)41)30-17-20-35-36(24-30)52-45(51-35)39-10-8-22-57(39)47(59)43(27(3)4)55-49(61)63-6/h11-14,17-20,24-27,31-32,38-39,42-43H,7-10,15-16,21-23H2,1-6H3,(H,50,53)(H,51,52)(H,54,60)(H,55,61)/t31-,32+,38-,39+,42+,43+/m1/s1
IUPAC Name
SMILES
COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C2=C1[C@@H]1CC[C@H]2C1)C1=CC=C2N=C(NC2=C1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C

References

General References
Not Available
ChemSpider
129234782
ChEMBL
CHEMBL5095203

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
3CompletedTreatmentChronic Hepatics C Virus (HCV) Genotype 1 / Cirrhosis of the Liver / Non-Cirrhotic / Treatment Naive1somestatusstop reasonjust information to hide
3CompletedTreatmentChronic Hepatitis C Virus (HCV) Infection1somestatusstop reasonjust information to hide
2CompletedTreatmentChronic Hepatics C Virus (HCV) Genotype 1 / Cirrhosis of the Liver / Non-Cirrhotic / Treatment Naive1somestatusstop reasonjust information to hide
2CompletedTreatmentChronic Hepatitis C Virus (HCV) Infection1somestatusstop reasonjust information to hide
1CompletedBasic ScienceHealthy Chinese Volunteers1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at June 19, 2024 17:53 / Updated at July 14, 2024 21:22